Why Investors Shouldn't Be Surprised By Sino Biopharmaceutical Limited's (HKG:1177) 31% Share Price Surge
Aug 04
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedAug 12, 2025
DataAggregated Company Financials
Companies38
- 7D1.6%
- 3M51.6%
- 1Y72.3%
- YTD81.1%
Last week, the Pharma industry hasn't moved much but CSPC Pharmaceutical Group is up 7.2% in that time. The past year has been better, since the industry has gained 73% in that time. As for the next few years, earnings are expected to grow by 12% per annum.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 12 Aug 2025 | HK$770.4b | HK$475.1b | HK$29.0b | 11.6x | 26.5x | 1.6x |
| Thu, 10 Jul 2025 | HK$668.5b | HK$475.3b | HK$28.7b | 11.3x | 23.3x | 1.4x |
| Sat, 07 Jun 2025 | HK$618.0b | HK$476.5b | HK$28.8b | 11.4x | 21.5x | 1.3x |
| Mon, 05 May 2025 | HK$513.1b | HK$467.5b | HK$28.6b | 10.4x | 17.9x | 1.1x |
| Wed, 02 Apr 2025 | HK$506.0b | HK$469.5b | HK$28.8b | 9.6x | 17.6x | 1.1x |
| Fri, 28 Feb 2025 | HK$459.2b | HK$462.3b | HK$31.9b | 8.7x | 14.4x | 1x |
| Sun, 26 Jan 2025 | HK$407.5b | HK$464.5b | HK$32.0b | 8.5x | 12.7x | 0.9x |
| Tue, 24 Dec 2024 | HK$432.2b | HK$460.2b | HK$31.8b | 8.4x | 13.6x | 0.9x |
| Thu, 21 Nov 2024 | HK$440.0b | HK$462.8b | HK$31.4b | 8.4x | 14x | 1x |
| Sat, 19 Oct 2024 | HK$503.8b | HK$472.0b | HK$32.8b | 7.8x | 15.4x | 1.1x |
| Mon, 16 Sep 2024 | HK$430.7b | HK$474.3b | HK$32.9b | 7.3x | 13.1x | 0.9x |
| Wed, 14 Aug 2024 | HK$441.6b | HK$463.0b | HK$32.9b | 7.5x | 13.4x | 1x |
| Fri, 12 Jul 2024 | HK$425.5b | HK$458.0b | HK$32.5b | 7.4x | 13.1x | 0.9x |
| Sun, 09 Jun 2024 | HK$474.5b | HK$463.7b | HK$33.9b | 8.4x | 14x | 1x |
| Tue, 07 May 2024 | HK$478.7b | HK$465.0b | HK$33.8b | 8.1x | 14.1x | 1x |
| Thu, 04 Apr 2024 | HK$447.1b | HK$465.0b | HK$36.5b | 7.6x | 12.3x | 1x |
| Sat, 02 Mar 2024 | HK$446.1b | HK$470.8b | HK$33.5b | 7.9x | 13.3x | 0.9x |
| Mon, 29 Jan 2024 | HK$418.0b | HK$472.4b | HK$33.8b | 7x | 12.4x | 0.9x |
| Wed, 27 Dec 2023 | HK$464.0b | HK$472.6b | HK$33.8b | 7.5x | 13.7x | 1x |
| Fri, 24 Nov 2023 | HK$517.2b | HK$472.7b | HK$32.4b | 7.1x | 16x | 1.1x |
| Sun, 22 Oct 2023 | HK$422.4b | HK$469.0b | HK$31.5b | 6.7x | 13.4x | 0.9x |
| Tue, 19 Sep 2023 | HK$430.0b | HK$469.4b | HK$31.6b | 6.8x | 13.6x | 0.9x |
| Thu, 17 Aug 2023 | HK$436.4b | HK$445.5b | HK$28.1b | 8.9x | 15.6x | 1x |
| Sat, 15 Jul 2023 | HK$481.2b | HK$447.6b | HK$28.0b | 9.4x | 17.2x | 1.1x |
| Mon, 12 Jun 2023 | HK$512.9b | HK$448.2b | HK$27.9b | 9.2x | 18.4x | 1.1x |
| Wed, 10 May 2023 | HK$552.7b | HK$453.0b | HK$28.4b | 9x | 19.5x | 1.2x |
| Fri, 07 Apr 2023 | HK$544.0b | HK$453.0b | HK$28.9b | 9.4x | 18.8x | 1.2x |
| Sun, 05 Mar 2023 | HK$606.4b | HK$443.5b | HK$34.0b | 12x | 17.8x | 1.4x |
| Tue, 31 Jan 2023 | HK$628.3b | HK$448.3b | HK$35.8b | 10.5x | 17.6x | 1.4x |
| Thu, 29 Dec 2022 | HK$590.1b | HK$441.7b | HK$34.7b | 10.8x | 17x | 1.3x |
| Sat, 26 Nov 2022 | HK$576.4b | HK$437.9b | HK$34.1b | 9.5x | 16.9x | 1.3x |
| Mon, 24 Oct 2022 | HK$570.5b | HK$511.8b | HK$38.7b | 8.9x | 14.7x | 1.1x |
| Wed, 21 Sep 2022 | HK$511.5b | HK$518.0b | HK$40.5b | 9.2x | 12.6x | 1x |
| Fri, 19 Aug 2022 | HK$570.0b | HK$512.2b | HK$51.2b | 7.9x | 11.1x | 1.1x |
Price to Earnings Ratio
11.1x
Current Industry PE
- Investors are optimistic on the Hong Kong Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 26.4x which is higher than its 3-year average PE of 15.6x.
- The 3-year average PS ratio of 1.1x is lower than the industry's current PS ratio of 1.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 17% per year over the last three years,
- Revenues have also declined 2.5% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 1.65% | |
| Healthcare | 2.75% | |
| Pharma | 1.60% | |
| Pharma | 1.60% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 867 China Medical System Holdings | HK$13.50 | 2.9% +HK$918.3m | 99.4% | PE18.4x | |
| 1093 CSPC Pharmaceutical Group | HK$10.04 | 0.4% +HK$457.3m | 70.2% | PE25.1x | |
| 1477 Ocumension Therapeutics | HK$10.55 | 3.9% +HK$325.5m | 60.3% | PS18.8x | |
| 460 Sihuan Pharmaceutical Holdings Group | HK$1.39 | 2.2% +HK$273.8m | 162.3% | PS6.1x | |
| 6622 Zhaoke Ophthalmology | HK$3.98 | 10.6% +HK$208.2m | 194.8% | PS28.8x |
